Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus + mFOLFOX6 in Metastatic Gastroesophageal Adenocarcinoma
NCT01231399Phase 2Completed
- Sponsor
- City of Hope
- Start
- Feb 2012
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in gastric adenocarcinoma, esophageal adenocarcinoma (EAC), gastroesophageal junction adenocarcinoma, sponsored by City of Hope. Started Feb 2012; status: completed.
02
Drugs
everolimus
03
Conditions
gastric adenocarcinomaesophageal adenocarcinoma (EAC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT01231399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01231399.